Tenofovir disoproxil fumarate withdrawal and cardiovascular risk
- PMID: 36566082
- DOI: 10.1016/S2352-3018(22)00362-9
Tenofovir disoproxil fumarate withdrawal and cardiovascular risk
Conflict of interest statement
RB reports grants and consulting fees from Merck and ViiV, also consulting fees from Gilead Sciences and Janssen. HD and CA declare no competing interests.
Comment in
-
Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply.Lancet HIV. 2023 Jan;10(1):e9-e10. doi: 10.1016/S2352-3018(22)00367-8. Lancet HIV. 2023. PMID: 36566083 No abstract available.
Comment on
-
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.Lancet HIV. 2022 Jul;9(7):e474-e485. doi: 10.1016/S2352-3018(22)00094-7. Epub 2022 Jun 7. Lancet HIV. 2022. PMID: 35688166
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical